Search

Carlos R Ortiz Rodriguez

Examiner (ID: 10220, Phone: (571)272-3766 , Office: P/2127 )

Most Active Art Unit
2119
Art Unit(s)
2125, 2119, 2123, 2127, 2122
Total Applications
923
Issued Applications
647
Pending Applications
77
Abandoned Applications
199

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11066105 [patent_doc_number] => 20160263069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'Therapeutic Compositions' [patent_app_type] => utility [patent_app_number] => 15/163295 [patent_app_country] => US [patent_app_date] => 2016-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24144 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163295 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/163295
Therapeutic compositions May 23, 2016 Issued
Array ( [id] => 11066106 [patent_doc_number] => 20160263070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'Therapeutic Compositions' [patent_app_type] => utility [patent_app_number] => 15/163454 [patent_app_country] => US [patent_app_date] => 2016-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24141 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15163454 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/163454
Therapeutic compositions May 23, 2016 Issued
Array ( [id] => 11066097 [patent_doc_number] => 20160263061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => 'DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 15/161778 [patent_app_country] => US [patent_app_date] => 2016-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10056 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161778 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/161778
DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST May 22, 2016 Abandoned
Array ( [id] => 11066138 [patent_doc_number] => 20160263101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-15 [patent_title] => '8\'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 15/161389 [patent_app_country] => US [patent_app_date] => 2016-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25835 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161389 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/161389
8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS May 22, 2016 Abandoned
Array ( [id] => 12765910 [patent_doc_number] => 20180147138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-05-31 [patent_title] => TRANSDERMAL LIQUID PREPARATION [patent_app_type] => utility [patent_app_number] => 15/574801 [patent_app_country] => US [patent_app_date] => 2016-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574801 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/574801
TRANSDERMAL LIQUID PREPARATION May 18, 2016 Abandoned
Array ( [id] => 13339651 [patent_doc_number] => 20180221365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE [patent_app_type] => utility [patent_app_number] => 15/573504 [patent_app_country] => US [patent_app_date] => 2016-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573504 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/573504
NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE May 10, 2016 Abandoned
Array ( [id] => 11127871 [patent_doc_number] => 20160324846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-10 [patent_title] => 'Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases' [patent_app_type] => utility [patent_app_number] => 15/152092 [patent_app_country] => US [patent_app_date] => 2016-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 41605 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15152092 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/152092
Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases May 10, 2016 Abandoned
Array ( [id] => 11074234 [patent_doc_number] => 20160271197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition' [patent_app_type] => utility [patent_app_number] => 15/144800 [patent_app_country] => US [patent_app_date] => 2016-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61562 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144800 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/144800
Drug Combinations and Uses in Treating a Coughing Condition May 1, 2016 Abandoned
Array ( [id] => 11074172 [patent_doc_number] => 20160271136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'Drug Combinations and Uses in Treating a Coughing Condition' [patent_app_type] => utility [patent_app_number] => 15/144798 [patent_app_country] => US [patent_app_date] => 2016-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61562 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15144798 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/144798
Drug Combinations and Uses in Treating a Coughing Condition May 1, 2016 Abandoned
Array ( [id] => 12170984 [patent_doc_number] => 09889100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Cannabidiol for treatment of severe and refractory graft-versus-host disease' [patent_app_type] => utility [patent_app_number] => 15/143694 [patent_app_country] => US [patent_app_date] => 2016-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14153 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15143694 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/143694
Cannabidiol for treatment of severe and refractory graft-versus-host disease May 1, 2016 Issued
Array ( [id] => 13478873 [patent_doc_number] => 20180290979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => COMPOSITION HAVING COMPOUND ACCELERATING PHOSPHORYLATION OF AMPK AS EFFECTIVE COMPONENT [patent_app_type] => utility [patent_app_number] => 15/570674 [patent_app_country] => US [patent_app_date] => 2016-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570674 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/570674
COMPOSITION HAVING COMPOUND ACCELERATING PHOSPHORYLATION OF AMPK AS EFFECTIVE COMPONENT Apr 27, 2016 Abandoned
Array ( [id] => 16459459 [patent_doc_number] => 10842787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-24 [patent_title] => Ophthalmic composition [patent_app_type] => utility [patent_app_number] => 15/568381 [patent_app_country] => US [patent_app_date] => 2016-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 49258 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568381 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/568381
Ophthalmic composition Apr 24, 2016 Issued
Array ( [id] => 13490073 [patent_doc_number] => 20180296579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => METHODS OF TREATING IBRUTINIB-RESISTANT DISEASE [patent_app_type] => utility [patent_app_number] => 15/568206 [patent_app_country] => US [patent_app_date] => 2016-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15568206 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/568206
METHODS OF TREATING IBRUTINIB-RESISTANT DISEASE Apr 17, 2016 Abandoned
Array ( [id] => 12603186 [patent_doc_number] => 20180092892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-04-05 [patent_title] => Compositions and Methods for Treating Anemia [patent_app_type] => utility [patent_app_number] => 15/563169 [patent_app_country] => US [patent_app_date] => 2016-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53532 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15563169 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/563169
Compositions and methods for treating anemia Mar 30, 2016 Issued
Array ( [id] => 12238513 [patent_doc_number] => 20180071376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-15 [patent_title] => 'TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS' [patent_app_type] => utility [patent_app_number] => 15/560276 [patent_app_country] => US [patent_app_date] => 2016-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21012 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560276 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560276
TOLEROGENIC NANOPARTICLES FOR TREATING DIABETES MELLITUS Mar 22, 2016 Abandoned
Array ( [id] => 13476225 [patent_doc_number] => 20180289655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases [patent_app_type] => utility [patent_app_number] => 15/559265 [patent_app_country] => US [patent_app_date] => 2016-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15559265 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/559265
Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological Diseases Mar 17, 2016 Abandoned
Array ( [id] => 10996219 [patent_doc_number] => 20160193165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'NOVEL POLYMORPHS AND SALTS' [patent_app_type] => utility [patent_app_number] => 15/072567 [patent_app_country] => US [patent_app_date] => 2016-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5342 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15072567 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/072567
NOVEL POLYMORPHS AND SALTS Mar 16, 2016 Abandoned
Array ( [id] => 13125631 [patent_doc_number] => 10080729 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-25 [patent_title] => Composition for use in the treatment of intervertebral misalignment [patent_app_type] => utility [patent_app_number] => 15/560138 [patent_app_country] => US [patent_app_date] => 2016-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 20 [patent_no_of_words] => 10820 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15560138 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/560138
Composition for use in the treatment of intervertebral misalignment Mar 16, 2016 Issued
Array ( [id] => 10995707 [patent_doc_number] => 20160192654 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'COMBINATIONS OF PYRIMETHANIL AND MONOTERPENES' [patent_app_type] => utility [patent_app_number] => 15/071493 [patent_app_country] => US [patent_app_date] => 2016-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4660 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15071493 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/071493
Combinations of pyrimethanil and monoterpenes Mar 15, 2016 Issued
Array ( [id] => 13457505 [patent_doc_number] => 20180280295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => SINGLE VIAL READY TO USE CABAZITAXEL FORMULATIONS WITH INCREASED STABILITY AND METHODS OF PREPARATIONS [patent_app_type] => utility [patent_app_number] => 15/068641 [patent_app_country] => US [patent_app_date] => 2016-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15068641 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/068641
SINGLE VIAL READY TO USE CABAZITAXEL FORMULATIONS WITH INCREASED STABILITY AND METHODS OF PREPARATIONS Mar 13, 2016 Abandoned
Menu